Abstract
This economic evaluation reviews the trends in list and net price data from SSR Health for the 2007 to 2019 period of self-administered systemic psoriasis medications manufactured in the United States.
Publication types
-
Research Support, N.I.H., Extramural
MeSH terms
-
Biological Products / administration & dosage
-
Biological Products / economics*
-
Cost of Illness
-
Dermatologic Agents / administration & dosage
-
Dermatologic Agents / economics*
-
Drug Costs / statistics & numerical data
-
Drug Costs / trends*
-
Drug Industry / economics
-
Drug Industry / statistics & numerical data
-
Drug Industry / trends*
-
Financial Support
-
Health Expenditures / statistics & numerical data
-
Health Expenditures / trends*
-
Humans
-
Psoriasis / drug therapy*
-
Psoriasis / economics
-
Self Administration / economics
-
Self Administration / statistics & numerical data
-
United States
Substances
-
Biological Products
-
Dermatologic Agents